General Discussion (Public Forum)
Living with pulmonary hypertension can be an isolating experience. Connect with other who know what it's like to manage chronic illness by joining myPHA. *** This is a public message board. Please keep this in mind when posting personal information. To view and participate in private message boards you must be a member of myPHA.
- 1 week, 4 days ago
- General Discussion (Public Forum)
The Pulmonary Hypertension Association (PHA) is recognizing both World PH Day and Lupus Awareness Month throughout the month of May. Lupus is a long-term autoimmune disease in which the body's immune system becomes hyperactive
At the end of March, the Food and Drug Administration (FDA) approved four generic versions of ambrisentan, the pulmonary arterial hypertension-targeted therapy marketed as the brand name Letairis®. All the new generic ambrisentan products
The Pulmonary Hypertension Association’s (PHA’s) PHPN Symposium, “Influencing the Practice: The Art and Science of Treating Pulmonary Hypertension,” Sept. 5-7, will feature a “limerick showdown” between Robert P. (Bob) Frantz, M.D., and Victor F.